首页> 外文期刊>Infection >Combination therapy with an aminoglycoside for Staphylococcus aureus endocarditis and/or persistent bacteremia is associated with a decreased rate of recurrent bacteremia: a cohort study
【24h】

Combination therapy with an aminoglycoside for Staphylococcus aureus endocarditis and/or persistent bacteremia is associated with a decreased rate of recurrent bacteremia: a cohort study

机译:一项队列研究:与氨基糖苷类药物联合治疗金黄色葡萄球菌心内膜炎和/或持续性菌血症与复发菌血症的发生率降低相关

获取原文
获取原文并翻译 | 示例
           

摘要

Although limited data exist on the efficacy and potential risk of synergistic aminoglycoside therapy for persistent Staphylococcus aureus bacteremia and endocarditis, aminoglycosides are frequently used in clinical practice.
机译:尽管关于持续性金黄色葡萄球菌菌血症和心内膜炎的协同氨基糖苷疗法的疗效和潜在风险的数据有限,但氨基糖苷类药物在临床实践中经常使用。

著录项

  • 来源
    《Infection》 |2011年第6期|p.549-554|共6页
  • 作者单位

    Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University, 11100 Euclid Ave., Cleveland, OH, 44106, USA;

    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA;

    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA;

    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号